VCYT
NASDAQ
$57.26
Veracyte Inc (VCYT)
Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $56.55 (-1.24%)
Market Cap
$4.75B
PEG Ratio
0.34
Revenue 5Y CAGR
+34.50%
Profit Margin
20.6%
Price Chart
Valuation
Market Cap$4.75B
P/E53.71
Forward P/E34.36
PEG0.34
P/S8.34
P/B3.41
Profitability
Total Revenue (TTM)$542M
Gross Profit (TTM)$395M
EBITDA$99M
Profit Margin20.6%
Operating Margin16.3%
EPS$1.11
Financial Health
Free Cash Flow Yield3.27%
Growth & Risk
Revenue 5Y CAGR+34.50%
Beta (5Y)1.36
Sharpe Ratio1.64